Analysis of seroprevalence against measles, rubella and mumps in health workers of two health departments of the Valencian Community (Spain)
e202211088
Keywords:
Health Personnel, Measles, Rubella, Mumps, Immunity, SerologyAbstract
BACKGROUND // Health Personnel are a professional group exposed to occupational risks. The aim of this paper was to estimate the absence of seroprotection against measles, rubella and mumps in health workers linked to two Health Departments of the Valencian Community (Spain) and to study the relationship with age, sex, professional category, occupational risk and performance área.
METHODS // A cross-sectional observational study was made. Data were collected from health surveillance reports, which included serological results from 2,674 health workers. The socio-demographic variables were: sex, age groups (18-34; 35-49; >50 years), service classification (risk/no risk), professional category, professional performance area (primary care/hospital care) and the dependent variable was absence of immunization against measles, rubella and mumps identified by the absence of serological levels. For the diseases studied, the prevalence of absence of seroprotection was estimated and the association between non-immunization and the rest of variables was evaluated.
RESULTS // Prevalence of non-immunization was 7.8%, 3.7% and 16.1% for measles, rubella and mumps, respectively. Logistic regression analysis showed a significant differences in the prevalence of non-immunization to measles according to age groups (adjusted OR 11.8 and adjusted OR 5.8) and professional performance area (adjusted OR 0.5), compared to mumps according to age groups (adjusted OR 4.9 and adjusted OR 3.6) and professional category 1 (doctors, pharmacists, dentists and psychologists) (adjusted OR 0.6) and against rubella according to sex (adjusted OR 4.6).
CONCLUSIONS // It is necessary to maintain vaccination among health workers, especially those who perform their functions in risk areas and among younger personnel. Vaccination should be promoted within occupational safety policies.
Downloads
References
Cervera JA, Gordillo PC, Goig MTF, Martí MJG, Soriano MJA, Pajares FG et al. Seroprevalencia frente a sarampión, rubeola y parotiditis en personal facultati-vo del servicio de pediatría del Hospital Universitario y Politécnico La Fe de Va-lencia. Rev Esp Salud Publica [Internet]. 2014 Sep 1 [cited 2022 Sep 2];88(5):653-659. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1135-57272014000500009&lng=es&nrm=iso&tlng=es
Rodríguez ML, Martínez Hernández D, Santos JM, Borda JR, Orero A. Seropreva-lencia de sarampión, rubéola, paperas y varicela en los trabajadores de un área sanitaria de la Comunidad de Madrid. Revista Española de Quimioterapia, ISSN-e 0214-3429, Vol 27, No 2, 2014, págs 98-101 [Internet]. 2014 [cited 2022 Sep 2];27(2):98-101. Disponible en: https://dialnet.unirioja.es/servlet/articulo?codigo=4755784&info=resumen&idioma=ENG
Botelho-Nevers E, Gautret P, Biellik R, Brouqui P. Nosocomial transmission of measles: an updated review. Vaccine [Internet]. 2012 Jun 8 [consultado 2022 Sep 2];30(27):3996-4001. Disponible en: https://pubmed.ncbi.nlm.nih.gov/22521843/
Wicker S, Rabenau HF, Marckmann G, Gottschalk R. [Nosocomial measles in-fections]. Dtsch Med Wochenschr [Internet]. 2013 [consultado 2022 Sep 2];138(47):2421-2425. Disponible en: https://pubmed.ncbi.nlm.nih.gov/24221979/
Almuneef MA, Memish ZA, Balkhy HH, Otaibi B, Helmi M. Seroprevalence sur-vey of varicella, measles, rubella, and hepatitis A and B viruses in a multina-tional healthcare workforce in Saudi Arabia. Infect Control Hosp Epidemiol [In-ternet]. 2006 Nov [consultado 2022 Sep 2];27(11):1178-1183. Disponible en: https://pubmed.ncbi.nlm.nih.gov/17080374/
Karadeniz A, Akduman Alaşehir E. Seroepidemiology of hepatitis viruses, mea-sles, mumps, rubella and varicella among healthcare workers and students: Should we screen before vaccination? J Infect Public Health [Internet]. 2020 Apr 1 [consultado 2022 Sep 2];13(4):480-484. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32113699/
Celikbas A, Ergonul O, Aksaray S, Tuygun N, Esener H, Tanir G et al. Measles, rubella, mumps, and varicella seroprevalence among health care workers in Turkey: is prevaccination screening cost-effective? Am J Infect Control [Inter-net]. 2006 Nov [consultado 2022 Sep 2];34(9):583-587. Disponible en: https://pubmed.ncbi.nlm.nih.gov/17097453/
Costa-Alcalde JJ, Trastoy-Pena R, Barbeito-Castiñeiras G, de la Cruz DN, Mejuto B, Aguilera A. Seroprevalence of antibodies against measles virus in galicia: Trends during the last ten years depending on age and sex. Revista Espanola de Quimioterapia. 2020 Apr 1;33(2):116-121.
Grupo de trabajo vacunación en población adulta y grupos de riesgo de la Po-nencia de Programa y Registro de Vacunaciones. Vacunación en grupos de ries-go de todas las edades y en determinadas situaciones. Comisión de Salud Pú-blica del Consejo Interterritorial del Sistema Nacional de Salud. Ministerio de Sanidad, Consumo y Bienestar Social, julio 2018. [Internet]. [consultado 2022 Sep 2]. Disponible en: https://www.sanidad.gob.es/profesionales/saludPublica/prevPromocion/vacunacio-nes/programasDeVacunacion/riesgo/docs/VacGruposRiesgo_todas_las_edades.pdf
Centers for Disease Control and Prevention. Immunization of Health-Care Per-sonnel Recommendations of the Advisory Committee on Immunization Practic-es (ACIP). MMWR 2011;60(RR-7):1-45. [consultado 2022 Sep 2]; Disponible en: http://www.cdc.gov/mmwr/cme/conted.html
Maltezou HC, Botelho-Nevers E, Brantsæter AB, Carlsson RM, Heininger U, Hübschen JM et al. Vaccination of healthcare personnel in Europe: Update to current policies. Vaccine [Internet]. 2019 Dec 10 [consultado 2022 Sep 2];37(52):7576-7584. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31623916/
Boletín Oficial del Estado. Ley 31/1995 de 8 de noviembre de Prevención de Riesgos Laborales. BOE núm. 269 de 10/11/1995. [Internet]. [consultado 2022 Sep 2]. Disponible en: https://www.boe.es/buscar/pdf/1995/BOE-A-1995-24292-consolidado.pdf
Boletín Oficial del Estado. Real Decreto Legislativo 2/2015, de 23 de octubre, por el que se aprueba el texto refundido de la Ley del Estatuto de Los Trabaja-dores. [Internet]. [consultado 2022 Sep 2]. Disponible en: https://www.boe.es/eli/es/rdlg/2015/10/23/2/con
Koenig KL, Shastry S, Mzahim B, Almadhyan A, Burns MJ. Mumps Virus: Modifi-cation of the Identify-Isolate-Inform Tool for Frontline Healthcare Providers. West J Emerg Med [Internet]. 2016 Sep 1 [consultado 2022 Sep 2];17(5):490–6. Disponible en: https://pubmed.ncbi.nlm.nih.gov/27625709/
Vázquez Rivas F, Mahíllo Fernández I, Vázquez Rivas F, Mahíllo Fernández I. Es-tado de inmunización frente a sarampión: utilidad de serología prevacunal en trabajadores de centros sanitarios. Revista de la Asociación Española de Espe-cialistas en Medicina del Trabajo [Internet]. 2020 [consultado 2022 Sep 2];29(2):29–34. Disponible en: https://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1132-62552020000200006&lng=es&nrm=iso&tlng=es
Jung J, Kim SK, Kwak SH, Hong MJ, Kim SH. Seroprevalence of Measles in Healthcare Workers in South Korea. Infect Chemother [Internet]. 2019 [consul-tado 2022 Sep 2];51(1):58-61. Disponible en: https://pubmed.ncbi.nlm.nih.gov/30941939/
Urbiztondo L, Borràs E, Costa J, Broner S, Campins M, Bayas JM et al. Preva-lence of measles antibodies among health care workers in Catalonia (Spain) in the elimination era. BMC Infect Dis [Internet]. 2013 Aug 26 [consultado 2022 Sep 2];13(1). Disponible en: https://pubmed.ncbi.nlm.nih.gov/23978316/
Borras̀ E, Campins M, Esteve M, Urbiztondo L, Broner S, Bayas JM et al. Are healthcare workers immune to rubella? Hum Vaccin Immunother [Internet]. 2014 [consultado 2022 Sep 2];10(3):686-691. Disponible en: https://pubmed.ncbi.nlm.nih.gov/24356729/
Campins M, Urbiztondo L, Costa J, Broner S, Esteve M, Bayas JM et al. Serolog-ical survey of mumps immunity among health care workers in the Catalonia re-gion of Spain. Am J Infect Control [Internet]. 2013 Apr [consultado 2022 Sep 2];41(4):378-380. Disponible en: https://pubmed.ncbi.nlm.nih.gov/23040604/
Kumakura S, Shibata H, Onoda K, Nishimura N, Matsuda C, Hirose M. Seroprev-alence survey on measles, mumps, rubella and varicella antibodies in healthcare workers in Japan: sex, age, occupational-related differences and vaccine efficacy. Epidemiol Infect [Internet]. 2014 Jan [consultado 2022 Sep 2];142(1):12-19. Disponible en: https://pubmed.ncbi.nlm.nih.gov/23574767/
Aypak C, Bayram Y, Eren H, Altunsoy A, Berktaş M. Susceptibility to measles, rubella, mumps, and varicella-zoster viruses among healthcare workers. J Nip-pon Med Sch [Internet]. 2012 [consultado 2022 Sep 2];79(6):453-458. Dis-ponible en: https://pubmed.ncbi.nlm.nih.gov/23291844/
Jung J, Kim SK, Kwak SH, Hong MJ, Kim SH. Seroprevalence of Measles in Healthcare Workers in South Korea. Infect Chemother [Internet]. 2019 [consul-tado 2022 Sep 2];51(1):58-61. Disponible en: https://pubmed.ncbi.nlm.nih.gov/30941939/
Andrew EC, Gibney KB, Denholm J, Leder K. Seroprotection to vaccine-preventable diseases among workers at a Victorian tertiary hospital. Aust N Z J Public Health [Internet]. 2016 Jun 1 [consultado 2022 Sep 2];40(3):284–-289. Disponible en: https://pubmed.ncbi.nlm.nih.gov/27027875/
Bianchi FP, Stefanizzi P, Trerotoli P, Tafuri S. Sex and age as determinants of the seroprevalence of anti-measles IgG among European healthcare workers: A systematic review and meta-analysis. Vaccine [Internet]. 2022 May 20 [consul-tado 2022 Sep 2];40(23):3127-3141. Disponible en: https://pubmed.ncbi.nlm.nih.gov/35491343/
Haviari S, Bénet T, Saadatian-Elahi M, André P, Loulergue P, Vanhems P. Vac-cination of healthcare workers: A review. Hum Vaccin Immunother [Internet]. 2015 [consultado 2022 Sep 4];11(11):2522. Disponible en: /pmc/articles/PMC4685699/
Lin MY, Shao HH, Tsou MT. Measles immunity in medical center staff after changes in national and local hospital vaccination policies. BMC Infect Dis [In-ternet]. 2022 Dec 1 [consultado 2022 Sep 2];22(1). Disponible en: https://pubmed.ncbi.nlm.nih.gov/35509007/
Cataldi JR, O’Leary ST, Beaty BL, Hurley LP, Crane LA, Brtnikova M et al. Measles Experience, Practice, and Knowledge by Pediatricians in the Context of Resur-gent US Outbreaks. J Pediatr [Internet]. 2022 Jul 1 [consultado 2022 Sep 2];246:213-219.e1. Disponible en: https://pubmed.ncbi.nlm.nih.gov/35427690/
Von Linstow ML, Nielsen AY, Kirkby N, Eltvedt A, Winther TN, Nielsen AB et al. Immunity to vaccine-preventable diseases among paediatric healthcare work-ers in Denmark, 2019. Euro Surveill [Internet]. 2021 [consultado 2022 Sep 4];26(17):1-9. Disponible en: https://pubmed.ncbi.nlm.nih.gov/33928900/
Kostinov MP, Loktionova MN, Shmitko AD, Polishchuk VB, Tatarinchik AA, Smir-nova OA et al. [Comparison of measles incidence in different age groups with the intensity of specific humoral immunity in healthcare workers in Moscow]. Vopr Virusol [Internet]. 2022 [consultado 2022 Sep 2];67(1):27-36. Disponible en: https://pubmed.ncbi.nlm.nih.gov/35293186/
Coppeta L, D’Alessandro I, Pietroiusti A, Somma G, Balbi O, Iannuzzi I et al. Se-roprevalence for vaccine-preventable diseases among Italian healthcare work-ers. https://doi.org/101080/2164551520201818523 [Internet]. 2020 [consulta-do 2022 Sep 4];17(5):1342-1346. Disponible en: https://www.tandfonline.com/doi/abs/10.1080/21645515.2020.1818523
García PB, Méndez MÁL, Monzón AN. [G1 mumps virus outbreak in the prov-ince of Almeria in 2005]. Rev Esp Salud Publica [Internet]. 2007 [consultado 2022 Sep 4];81(6):605-614. Disponible en: https://pubmed.ncbi.nlm.nih.gov/18347744/
Trevisan A, Bertoncello C, Artuso E, Frasson C, Lago L, de Nuzzo D et al. Will We Have a Cohort of Healthcare Workers Full Vaccinated against Measles, Mumps, and Rubella? Vaccines 2020, Vol 8, Page 104 [Internet]. 2020 Feb 27 [consulta-do 2022 Sep 4];8(1):104. Disponible en: https://www.mdpi.com/2076-393X/8/1/104/htm
Dabbagh AJ, Dumolard L, Gacic-Dobo M, Grant GB, Reef SE. Rubella and Con-genital Rubella Syndrome Control and Elimination-Global Progress, 2000-2012. Morbidity and Mortality Weekly Report [Internet]. 2013 Dec 12 [consultado 2022 Sep 4];62(48):983. Disponible en: https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6248a3.htm
Sanz JC, de Ory F. Rubéola: el nuevo escenario de una vieja enfermedad. Enferm Infecc Microbiol Clin [Internet]. 2006 Jan 1 [consultado 2022 Sep 4];24(1):36-44. Disponible en: https://www.elsevier.es/es-revista-enfermedades-infecciosas-microbiologia-clinica-28-articulo-rubeola-el-nuevo-escenario-una-13083374
Hase R, Niiyama Y, Mito H. Evaluation of the seroprevalence of measles, rube-lla, mumps, and varicella and the requirement for additional vaccination based on the JSIPC guidelines among emergency medical technicians at eight fire stations in Narita, Japan: a project review. Hum Vaccin Immunother [Internet]. 2022 [consultado 2022 Sep 2];18(1). Disponible en: https://pubmed.ncbi.nlm.nih.gov/34756159/
Kawamura K, Wada H, Nakasone H, Akahoshi Y, Kawamura S, Takeshita J et al. Immunity and Vaccination Against Measles, Mumps, and Rubella in Adult Allo-geneic Hematopoietic Stem Cell Transplant Recipients. Transplant Cell Ther. 2021 May 1;27(5):436.e1-436.e8.
Sánchez-Payá J, Hernández-García I, García-Román V, Camargo-Angeles R, Ba-rrenengoa-Sañudo J, Villanueva-Ruiz CO et al. Influenza vaccination among healthcare personnel after pandemic influenza H1N1. Vaccine. 2012 Jan 20;30(5):911-915.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2022 Vicente García Román , José Luis Mendoza García , Isidra Tenza Iglesias , Esther Martínez Martínez-Carrasco, José Luis Duro Torrijos, Elena Ronda Pérez
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Usted es libre de:
Compartir — copiar y redistribuir el material en cualquier medio o formato.
La licenciante no puede revocar estas libertades en tanto usted siga los términos de la licencia.
Bajo los siguientes términos:
Atribución — Usted debe dar crédito de manera adecuada , brindar un enlace a la licencia, e indicar si se han realizado cambios. Puede hacerlo en cualquier forma razonable, pero no de forma tal que sugiera que usted o su uso tienen el apoyo de la licenciante.
NoComercial — Usted no puede hacer uso del material con propósitos comerciales.
SinDerivadas — Si remezcla, transforma o crea a partir del material, no podrá distribuir el material modificado.
No hay restricciones adicionales — No puede aplicar términos legales ni medidas tecnológicas que restrinjan legalmente a otras a hacer cualquier uso permitido por la licencia.
Avisos:
No tiene que cumplir con la licencia para elementos del material en el dominio público o cuando su uso esté permitido por una excepción o limitación aplicable.
No se dan garantías. La licencia podría no darle todos los permisos que necesita para el uso que tenga previsto. Por ejemplo, otros derechos como publicidad, privacidad, o derechos morales pueden limitar la forma en que utilice el material.
